5.285
Candel Therapeutics Inc (CADL) 最新ニュース
How Candel Therapeutics Inc. stock trades before earningsJuly 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
Is Candel Therapeutics Inc. stock recession proof2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Is Candel Therapeutics Inc. stock attractive after correctionWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
Is Candel Therapeutics Inc. stock resilient to inflationPortfolio Update Summary & Safe Capital Investment Plans - Newser
Candel: lighting the path to a brighter future for patients with solid tumors - Nature
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - MSN
Candel Therapeutics Stock Headed For 20% Weekly Gains: Retail Over The Moon With BofA's 'Buy' Call - MSN
Candel Therapeutics stock price target raised to $14 by Freedom Capital - Investing.com Nigeria
Will Candel Therapeutics Inc. stock gain from strong economy2025 Price Targets & High Accuracy Trade Alerts - newser.com
What technical models suggest about Candel Therapeutics Inc.’s comebackIndex Update & Safe Entry Zone Tips - newser.com
Why Candel Therapeutics Inc. stock could see breakout soon2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
How geopolitical tensions affect Candel Therapeutics Inc. stockPortfolio Update Report & Stepwise Trade Signal Guides - newser.com
How Candel Therapeutics Inc. stock performs in stagflationJuly 2025 Earnings & Technical Buy Zone Confirmations - newser.com
Candel Therapeutics Inc. (CADL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Candel Therapeutics Inc. building a consolidation baseShare Buyback & AI Powered Market Trend Analysis - newser.com
Candel Therapeutics to host virtual Research & Development event - Proactive Investors
Candel Therapeutics, Inc. Announces Virtual Research and Development Day for December 5, 2025 - Quiver Quantitative
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 - The Manila Times
Candel Therapeutics (Nasdaq: CADL) Sets Virtual R&D Event on Immuno-Oncology, CAN-2409 and CAN-3110 - Stock Titan
Will Candel Therapeutics Inc. stock benefit from automationJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
How Candel Therapeutics Inc. stock compares to growth peersJuly 2025 Highlights & Verified Entry Point Signals - newser.com
What’s next for Candel Therapeutics Inc. stock price2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Will Candel Therapeutics Inc. see short term momentumWeekly Stock Summary & Consistent Profit Trade Alerts - newser.com
Analysts’ Top Healthcare Picks: Candel Therapeutics (CADL), Pfizer (PFE) - The Globe and Mail
Candel Therapeutics Broadens Its Clinical Cancer Studies - Kalkine Media
Citigroup Maintains Candel Therapeutics (CADL) Buy Recommendation - Nasdaq
Candel Therapeutics (CADL) Analyst Rating Update: Citigroup Lowe - GuruFocus
Candel Therapeutics Reports Wider Loss, But Analysts Stay Upbeat - Finimize
Candel pausing development of CAN-2409 in pancreatic cancer type - Seeking Alpha
大文字化:
|
ボリューム (24 時間):